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Edited by Takashi GojoboriAbstract In Gram-negative bacteria, drug resistance is due in
part to the activity of transmembrane eﬄux-pumps, which are
composed of three types of proteins. A representative pump from
Escherichia coli is an assembly of the trimeric outer-membrane
protein TolC, which is an allosteric channel, the trimeric inner-
membrane proton-antiporter AcrB, and the periplasmic protein,
AcrA. The pump displaces drugs vectorially from the bacterium
using proton electrochemical force. Crystal structures are avail-
able for TolC and AcrB from E. coli, and for the AcrA homo-
logue MexA from Pseudomonas aeruginosa. Based on
homology modelling and molecular docking, we show how AcrA,
AcrB and TolC might assemble to form a tripartite pump, and
how allostery may occur during transport.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The therapeutic treatment of bacterial infection is frustrated
frequently by the ability of the pathogen to acquire drug resis-
tance. Such resistance is often caused by the activity of trans-
membrane transporters that recognize and expel eﬃciently
from the cells a broad range of structurally unrelated cytotoxic
drugs and xenobiotic compounds [1,2]. In the case of Gram-
negative bacteria, which are characterized by a protective dou-
ble-membrane system, an important group of drug eﬄux
pumps is based on a tri-partite assembly, which is composed
of an outer-membrane (OM) protein, an inner-membrane
(IM) proton antiporter and a periplasmic membrane fusion
protein (MFP) that links all these components [3–5]. These
pumps transduce electrochemical energy to displace the drugs
directionally.Abbreviations: OM, outer-membrane; IM, inner-membrane; MFP,
membrane fusion protein; RND, resistance-nodulation-division; MFS,
major facilitator superfamily
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doi:10.1016/j.febslet.2004.10.097A representative pump that expels acridine and other com-
pounds from Escherichia coli is shown schematically in Fig.
1(a). The TolC protein of this pump is a representative mem-
ber of the OM family of eﬄux pump components. In E. coli,
TolC has the ability to interact with diﬀerent classes of IM pro-
ton antiporters, which may belong either to the resistance nod-
ulation and cell division family (RND) or to the major
facilitator superfamily (MFS) [6,7]. A typical drug eﬄux pump
observed in E. coli is formed by the RND protein AcrB [8,9],
the MFP AcrA, and the OM channel TolC [10,11]. Insight into
the mechanism of multidrug transport has been attained with
the determination of the crystal structures of TolC [12], AcrB
[8,13] and more recently MexA, a MFP from Pseudomonas
aeruginosa that is a close homologue to AcrA [14,15] (see
Fig. 1 for a gallery of these components). TolC and AcrB both
form homotrimers, and both contain sealed channels that are
likely to be opened during the transport process.
The question remains as to how these three proteins assem-
ble to form a functional pump and how channel opening oc-
curs. Here, we have explored the possible interactions
between TolC, AcrB and AcrA by homology modelling and
molecular docking. We propose a structural model for the tri-
partite complex, where the TolC channel is stabilized in an
open conformation state by interacting with the coiled-coil do-
main of AcrA, which in turn interacts with the IM protein
AcrB to bridge the IM and OM proteins. This model may ex-
plain transport through homologous pumps amongst the
Gram-negative bacteria.2. A homology model of AcrA
The crystal structure of MexA reveals an intricate fold that
is a composite of structural domains found widely in nature.
As successfully predicted by Johnson and Church [16], the core
of this MFP has structural similarity with the ‘‘lipoyl/biotinyl’’
domain, which occurs in the extensive family of proteins that
are modiﬁed by a lipoyl group or biotin. Emanating from
the lipoyl/biotinyl domain, there is a pair of a-helices that form
a classical coiled-coil, with the characteristic knobs-into-holes
intermeshing of hydrophobic residues. This internal interface
is structurally invariant amongst the 13 copies of MexA that
occupy the crystallographic asymmetric unit in non-equivalent
packing environments, and it is unlikely to undergo any
type of plastic deformation on engagement with the otheration of European Biochemical Societies.
Fig. 1. Eﬄux pumps from Gram-negative bacteria. (a) A schematic
representation of the assembly of the acridine-eﬄux pump from E. coli.
Also shown are the crystal structures of representative components of
bacterial eﬄux pumps: (b) the E. coli OM protein TolC, a homotrimer;
(c) the trimeric E. coli AcrB IM protein, and (d) the Pseudomonas
aeruginosa MexA MFP. The AcrB and TolC molecules are orientated
with the molecular threefold axes orientated vertically.
Fig. 2. A comparison of the closed (resting) and open states of TolC
and the docking of AcrA. The views in part a, b, and c show the
aperture end of TolC, from the perspective of the IM partner protein.
Presented here are the closed state, from the crystal structure (a); the
open state, as modelled on the internal molecular symmetry (b); the
open state with the coiled-coil domain from AcrA docked in the inter-
protomer interface (c). In (d), the TolC–AcrA complex has been
rotated so that the molecular threefold axis is vertical. AcrA was
prepared by homology modelling.
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conserve the core of the lipoyl/biotinyl domain as well as the
coiled-coil; however, the length of the coiled-coil is variable –
a point that will become important later in the analysis of
the docking model. The coiled-coil region of AcrA is predicted
to be 14 residues longer than the one in MexA, and based on
the assumption that this region will make an elongated coiled-
coil, a model of AcrA was created (details in Fig. 2 legend).3. The open state of TolC and the docking of AcrA
Like AcrB, the TolC protein is a homotrimer. Also, in both
proteins it appears that the subunit originated through a gene
duplication event, which has left a signature as a recognizable
structural repeat within the protomer. The TolC open state
was modelled on the basis of this structural repeat, by simply
assuming that the coiled-coil portion of the two halves has
quasi-equivalent super-helical geometry [17]. On comparing
the open and closed states, we were struck by the appearance
of an exposed groove at the interface of the subunits that oc-
curs at the boundary of adjacent coiled-coils (Fig. 2(b)). We
found that this groove could easily accommodate an a-helix
with a gentle super-helical trajectory [18]. The docked helix
can form contacts with the exposed helices of TolC to form,
locally, a helical bundle. Based on this observation, we manu-
ally docked the AcrA model into the open state of TolC. A to-tal of eight diﬀerent possible docking orientations of AcrA
with respect to TolC were obtained with this manual proce-
dure. These AcrA/TolC docking complexes were further
reﬁned using a procedure for optimization of interface side-
chain conformation (ICM-DISCO; [19,20]). We found an opti-
mal local energy minimum, with scoring energy of 40.5 kcal/
mol (Table 1), which forms close interfacial contacts (Fig.
2(c)). Three such interfacial grooves are present in the TolC tri-
mer, and so three AcrA protomers can be accommodated. Two
other docking orientations (ranked second and third in Table
1) were considered for further modelling. The conformation
ranked number four, although it had only slightly less favour-
able value for the scoring-energy, was not considered for fur-
ther modelling because it occluded the bottom of the TolC
channel. The scoring energy used here to evaluate the docking
results represents the balanced sum of contributions from the
van der Waals, electrostatics, hydrogen bonding and desolva-
tion binding energies, which have been optimized with datasets
of known protein–protein complexes [19,21]. This model repre-
sents the ﬁrst part of the tripartite pump.4. Docking of TolC and AcrA onto the AcrB trimer
We analyzed the surface of TolC for sites that are likely to
interact with other proteins, using a method that ﬁnds Optimal
Docking Areas (ODAs), i.e. regions with optimal desolvation
energy for protein binding [22]. In general, ODAs with values
smaller than 15.0 kcal/mol are more than 80% likely to be
Table 1
Results of the diﬀerent docking/reﬁnement runs

















1 40.5 0.0 1 45.4 0.0 1 77.0 0.0 1 82.6 0.0
2 34.1 5.4 2 42.8 16.1 2 74.3 5.6 2 82.4 4.3
3 33.6 6.3 3 29.6 16.4 3 72.9 9.9
4 33.0 22.5 4 28.2 15.9 4 72.8 8.3
5 26.2 24.1 5 18.8 13.4 5 72.7 4.8
6 22.6 8.4 6 10.0 9.9 6 69.9 6.2
7 19.9 22.2
8 14.1 24.2
aReﬁnement of TolC/AcrA docking solutions 1–3 combined with TolC/AcrB docking solutions 1 and 2.
bReﬁnement of AcrA ﬁnal model with TolC/AcrB docking solutions 1 and 2. See text for details.
cRMSD calculated for the interface (4 A˚ from receptor) ligand Ca atoms when TolC molecules are superimposed. Values referred to the lowest-
energy docking solution.
dRMSD calculated for the interface (4 A˚ from receptor) AcrA Ca atoms when TolC/AcrB molecules are superimposed. Values referred to the lowest-
energy docking solution.
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has been previously determined in a large data set of known
protein–protein complexes. In both the open and closed states
of TolC, the portions with greatest propensity for interaction,
with values of up to 26.4 and 33.6 kcal/mol for open and
closed states, respectively, are the inter-helical loops near the
aperture (the bottom portion shown in Fig. 1(b)). This region
is not predicted to interact with AcrA according to our model,
but it can potentially match to the funnel shaped surface of the
periplasmic domain of AcrB (Fig. 1(c)). The direct interme-
shing of TolC with AcrB has been proposed by Murakami
et al. [8], whereby the inter-helical loops of TolC meet the sur-
face concavity present in AcrB. In this model, the threefold
molecular symmetry axes of TolC and AcrB are coincident.
We explored and reﬁned a more detailed model for the direct
docking of AcrB with the open state TolC. To proceed, we ﬁrst
noted that both the TolC and AcrB trimers expose six inter-
helical loops for potential contact; these arise from the approx-
imate structural repeat within the protomer that we described
earlier. As these protrusions all lie in a ring, they form the
shape of a six-pointed crown. We sought the global energy
minimum of the interaction between the open state of TolC
and AcrB by performing an unrestricted rigid-body 2-dimen-
sional search of rotations around the coincident threefold sym-
metry axes and translation along this axis. The rigid-body
conformational search and subsequent interface side-chain
reﬁnement were performed as previously described [19,20].
We found two major minima in which TolC and AcrB were
intermeshed in two non-equivalent ways (scoring energies
45.4 and 42.8 kcal/mol, respectively). The lower energy
solution is shown in Fig. 3(a); the second one was not chosen
for further reﬁnement because it caused a steric clash of AcrA
with the AcrB in the next stages of modelling (see below). The
remaining docking orientations were clearly less favourable
energetically (Table 1). For comparison, we have docked the
closed conformation of TolC onto AcrB, but the resulting con-
formations, equivalent to the ones obtained for the open TolC/
AcrB docking, had less favourable energy values (36.1 and
29.3 kcal/mol, respectively).
We reﬁned the three selected models described in the pre-
vious section for AcrA/TolC interaction, in the context of the
two possible modes of TolC/AcrB interaction describedabove. However, the resulting solutions were not yet optimal,
in spite of their reasonable energy values, because of the fact
that AcrA backbone was initially considered rigid, as ex-
plained below. It is interesting to note that the AcrB trimer
has a striking canyon-like groove along the interface of the
entire periplasmic domain. With the constraint that the AcrA
coiled-coil tracks along the TolC groove, the lipoyl/biotinyl
domain exits the TolC in the vicinity of this AcrB interfacial
groove. This domain can be accommodated into the AcrB
groove, but not simultaneously with the ﬁt of the coiled-coil
domain in the TolC groove, when the AcrA backbone is
rigid.
However, with a modest structural adjustment, the AcrA
can engage both grooves simultaneously. The connecting re-
gion between the coiled-coil and lipoyl/biotinyl domains is thus
predicted to act as a conformational switch. The putative
switch provides an explanation for the observed phenotypes
of several previously described MexA mutations which are lo-
cated in this region and have been shown to impede MexA–
MexB association and MexA self-association [23].
We suggest that the lipoyl/biotinyl domain would be accom-
modated in the intra-subunit gap of AcrB, with slight confor-
mational strain, to form a closed seal between TolC, AcrA and
AcrB. We built a TolC/AcrB/AcrA model by superimposing
the AcrA coiled-coil domain onto the best solution obtained
from the TolC/AcrA docking (described before; see Fig. 2(c))
and the AcrA lipoyl/biotinyl domain onto a selected solution
of the TolC/AcrB/AcrA reﬁnement, where the lipoyl/biotinyl
domain had good interface complementarity to AcrB. This
was performed for each of the two possible TolC/AcrB orien-
tations, and the ﬁnal energy values obtained for the reﬁned
complex models were 82.6 and 82.4 kcal/mol, respectively,
better than when AcrA was considered as a rigid-body. This
energy value accounts not only for the binding of AcrA onto
the TolC/AcrB complex, but also for the previous binding of
TolC onto AcrB. Our ﬁnal lowest-energy model, incorporating
the required match of TolC and AcrB and the accommodation
of AcrA into the interfacial grooves of both its partners, is
shown in Fig. 3(b). When we used the closed form of TolC,
we obtained less favourable energy values for the ﬁnal models
in which AcrA was bound onto the two possible closed TolC/
AcrB orientations (75.2 and 69.2 kcal/mol, respectively).
Fig. 3. Two views of the AcrA–AcrB–TolC assembly. In (a), the
threefold molecular axis is vertical, and in (b), the view is along the
threefold axis. AcrA is predicted to ﬁt simultaneously in the inter-
protomer grooves of TolC and AcrB, with conformational strain.
Initially, AcrA best model was docked manually onto the TolC
structure using Insight II software (Accelrys). We placed 2 models of
AcrA by positioning its coiled-coil domain such that it forms a helical
bundle with the two helices of TolC. The 3D coordinates for this TolC/
AcrA complex were submitted to a rigid body simulation-docking
program based on multi-start global energy optimization of an all-
atom model of AcrA. The ensembles of the rigid-body docking
solutions generated by the simulations were subsequently used to
project the docking energy landscapes onto the protein surface.
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more strongly to AcrB and AcrA than the closed one.
Our model can account for the eﬀects of mutations in the
homologous MexA that abolish MexA–MexB association,
but which do not impede self-association of the protein. These
mutations map to the lipoyl/biotinyl domain and lie in close
vicinity of the AcrB surface [23]. Some of these, notably
L301 and R294, are inferred by our model to be in direct con-
tact with the AcrB. Our model also provides a rationalization
of the experimental data of Touze and Eswaran [24], showing
that truncation of the N-terminal portion of AcrA abolishes
binding to TolC but not to AcrB.5. Methods
After searching for the best template with the web-based programs
FUGUE and HOMSTRAD [25–28], 3D homology models of AcrA
were built with the template crystal structures of MexA (PDB entry
1vf7). The alignments were performed with FUGUE and annotated
with JOY [29]. After examinations of the alignments, 15 models were
generated using MODELLER [30] and these were ranked by analysis
of their stereochemistry using PROCHECK [31] and their sequence–
environment compatibility using VERIFY 3D [32,33]. From the
ensemble, the highest-ranking structure on the basis of these criteria
was selected for further analysis and as a starting structure for docking
simulations. All ﬁgures have been prepared using the programs MOL-
SCRIPT [34] and rendered using Raster3D [35].6. Conclusions and discussion
To date, there is no deﬁnitive experimental data for the stoi-
chiometric composition of an engaged transport pump. The
model we have prepared predicts a protomer stoichiometry
of 1:1:1 for OM:MFP:IM components of the tripartite pump.
An alternative model for the pump has also been suggested
based on the compositional ratio of 1:3:1 and this requires that
the MFP forms an enclosing sheath around the TolC [15]. A
model of 1:2:1 has also been proposed in which the helices
of the coiled-coil are inclined with the surface of TolC and
do not ﬁt into the inter-subunit grooves [14]. Our model diﬀers
from both in that it predicts the alignment of the coiled-coil of
the MFP within a groove with shape complementarity in the
open state of TolC, and it also predicts the direct interaction
of OM and IM components, which is not possible in the mod-
els of Akama et al. [14] and Higgins et al. [15]. We note that
while the proposed model is applicable for the AcrA–AcrB–
TolC system, diﬀerent arrangement of the MFPs can be
expected in ABC and MFS-based pumps. Thus, in the haem-
olysin transporter, which uses an IM ATPase, the MFP com-
ponent may form a closed tube [17], like that proposed by
Higgins et al. [15] for MexA.
Experimental evidence suggests that TolC can be found in
isolation from the other pump components and this implies
that it must be in the closed, resting state; otherwise it would
provide a large open pore in the OM. The allosteric transition
in TolC to its open state is likely to be favoured by interactions
with the other components of the tripartite pumps and we have
shown here how the grooves of the open state of TolC can be
matched favourably by the MFP partner. We also propose
that, with a structural adjustment, the lipoyl/biotinyl domain
of AcrA will dock into clefts in the periplasmic surface of
the AcrB trimer to form the tripartite pump. In our model,
J. Fernandez-Recio et al. / FEBS Letters 578 (2004) 5–9 9the AcrB pore is closed, and the question arises as to how it is
opened during the transport process. The crystal structure of
AcrB in complex with drugs shows that these ligands do not
trigger the opening of the periplasmic pore, and it therefore
seems likely that pore opening may require the binding of
drug, the conduction of protons and the protein–protein inter-
actions with TolC and AcrA. Thus, the simultaneous engage-
ment of the MFP with the IM and OM, and the allosteric
transitions triggered through drug binding and proton conduc-
tion, may ensure the orchestrated opening of the IM pore and
the vectorial transport of drug.
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